首药控股 funding history / development milestones

IPO上市，

2022.03.23，上交所

Note: collected from public online reports, for reference only.

Talent Demand Trend Analysis More

创新药

药物研发

临床医学

创新药物

原研药

医药科技

医药工业

People who follow 首药控股 also follow

首药控股 Competitors (Similar Companies)

Follow in Bulk Copy Company Names

Beijing Great Wall Pharmaceutical Co., Ltd.

制药/药业医药医药工业生产

Pfizer Investment Co., Ltd.

“Continuously innovating to bring patients medicines that significantly”

Pharmaceutical Research Associates, Inc. (Pharmaron Beijing) Co., Ltd.

“Helping partners successfully develop new drugs, reducing R&D costs an”

Shanghai Southern Model Biotechnology Co., Ltd.

“Dedicated to model animals for 24 years”

宁波熙宁检测技术有限公司

“临床和临床前大分子生物分析一站式服务”

Shanghai Roche Pharmaceuticals Co., Ltd.

制药/药业抗肿瘤药肿瘤检测神经系统疾病药物

Boji Pharmaceutical Technology Co., Ltd.

“One-stop full-process outsourcing services for drug and medical device”

Chongqing Zhifei Biological Products Co., Ltd.

“Serving human pharmaceutical and health undertakings”

Shanghai Bluewood Chemical Co., Ltd.

“High-quality life science reagents”

Beijing Saisheng Pharmaceutical Co., Ltd.

“Pursuing health for all”

Langzhi Group Co., Ltd.

医药药物研发大健康药材种植

成都创思立信信息技术有限公司

流程自动化软件翻译特殊教育

江苏瑞思坦生物科技有限公司

生物科技/生物工程干细胞再生医学细胞治疗

Guangzhou Wondfo Biotech Co., Ltd.

“Rapid test product R&D and manufacturer”

Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

合成生物学脑科学人工智能科研机构

中 中文版 View this page in Chinese ›